drugset / Trial / NCT04267250

Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

NCT04267250

Phase 1 Completed 18 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

This Phase 1 study will assess the pharmacokinetic effect of multiple doses PF 06700841 (administered once a day) on a single dose of a combination oral contraceptive, in 18 healthy female participants who are not of childbearing potential.

Timeline

Start
2020-08-24
Primary completion
2020-11-06
Completion
2020-11-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Brepocitinib Small molecule 60 mg Oral
Subject Levonorgestrel Small molecule 150 ug Oral
Subject ethinyl estradiol Small molecule 30 ug Oral

Indications

No indication recorded.